Literature DB >> 22766788

Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection.

Elen B Blochin1, Kay J Park, Satish K Tickoo, Victor E Reuter, Hikmat Al-Ahmadie.   

Abstract

Squamous cell carcinomas of the urinary bladder are rare in the Western world; the majority of cases are reported in countries endemic to Schistosoma parasitic infections. Unlike squamous tumors of the uterine cervix or oropharynx, the human papillomavirus (HPV) is not commonly associated with bladder squamous cell carcinomas. We report on two cases of HPV-positive urothelial carcinomas of the urinary bladder with extensive squamous differentiation showing the typical basaloid, poorly differentiated morphology of HPV-associated tumors. These occurred in patients with neurogenic bladders who had long-standing histories of self-catheterization with tumors that tested positive for HPV by in situ hybridization. A retrospective review of our institutional database revealed four additional patients with bladder tumors showing squamous differentiation arising in the setting of neurogenic bladder. Review of these cases showed the more common well-differentiated keratinizing appearance of squamous cell carcinomas of the bladder. These tumors showed only patchy positivity for p16 immunohistochemical stain (not the diffuse strong staining seen in HPV-positive tumors), and the one tested case was negative for HPV by in situ hybridization. HPV infection and neurogenic bladder have been independently associated with increased risk of developing carcinoma in the urinary bladder; however, this is the first report of squamous tumors arising in the setting of concurrent neurogenic bladder and HPV infection. The morphology of these tumors is similar to that of other high-risk HPV-associated squamous carcinomas with a basaloid, poorly differentiated appearance and little to no keratin formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766788     DOI: 10.1038/modpathol.2012.112

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  6 in total

1.  Papillary urothelial carcinoma with squamous differentiation in association with human papilloma virus: case report and literature review.

Authors:  Sergei Guma; Remegio Maglantay; Ryan Lau; Rosemary Wieczorek; Jonathan Melamed; Fang-Ming Deng; Ming Zhou; Danil Makarov; Peng Lee; Matthew R Pincus; Zhi-Heng Pei
Journal:  Am J Clin Exp Urol       Date:  2016-01-28

2.  Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cancer with squamous differentiation.

Authors:  Sung Han Kim; Jae Young Joung; Jinsoo Chung; Weon Seo Park; Kang Hyun Lee; Ho Kyung Seo
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

Review 3.  Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.

Authors:  Joshua J Meeks; Hikmat Al-Ahmadie; Bishoy M Faltas; John A Taylor; Thomas W Flaig; David J DeGraff; Emil Christensen; Benjamin L Woolbright; David J McConkey; Lars Dyrskjøt
Journal:  Nat Rev Urol       Date:  2020-03-31       Impact factor: 14.432

4.  HRAS mutations are frequent in inverted urothelial neoplasms.

Authors:  Andrew S McDaniel; Yali Zhai; Kathleen R Cho; Saravana M Dhanasekaran; Jeffrey S Montgomery; Ganesh Palapattu; Javed Siddiqui; Todd Morgan; Ajjai Alva; Alon Weizer; Cheryl T Lee; Arul M Chinnaiyan; Michael J Quist; Catherine S Grasso; Scott A Tomlins; Rohit Mehra
Journal:  Hum Pathol       Date:  2014-06-18       Impact factor: 3.466

5.  Bladder cancer and human papillomavirus association: a systematic review and meta-analysis.

Authors:  Alireza Khatami; Zahra Salavatiha; Mohammad Hossein Razizadeh
Journal:  Infect Agent Cancer       Date:  2022-01-21       Impact factor: 2.965

6.  Detection of HPV infection in urothelial carcinoma using RNAscope: Clinicopathological characterization.

Authors:  Fidele Y Musangile; Ibu Matsuzaki; Mitsuaki Okodo; Ayaka Shirasaki; Yurina Mikasa; Ryuta Iwamoto; Yuichi Takahashi; Fumiyoshi Kojima; Shin-Ichi Murata
Journal:  Cancer Med       Date:  2021-06-23       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.